Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
6(55%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
9%
Ph not_applicable
8
73%
Ph phase_1
1
9%

Phase Distribution

1

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
1(10.0%)
Phase 2Efficacy & side effects
1(10.0%)
N/ANon-phased studies
8(80.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

6

trials recruiting

Total Trials

11

all time

Status Distribution
Active(7)
Completed(3)
Terminated(1)

Detailed Status

Recruiting6
Completed3
Withdrawn1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
6
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (10.0%)
Phase 21 (10.0%)
N/A8 (80.0%)

Trials by Status

withdrawn19%
completed327%
not_yet_recruiting19%
recruiting655%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
11